Prednisone tablet

DRUG12 trials

Sponsors

ALK-Abelló A/S, Carmel Medical Center, Maria Joyera Rodríguez, Inge Marie Svane, Czech Lymphoma Study Group

Conditions

Allergic Bronchopulmonary AspergillosisAllergyBell PalsyCovid19Hearing LossHepatitis, Drug-InducedImmune Thrombocytopenia With Positive ANA AntibodiesLymphoma, T-Cell, Peripheral

Phase 1

Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.

TerminatedNCT05276492

University of ChicagoProstate Adenocarcinoma, Prostate Cancer, Prostate Cancer Metastatic +1

Start: 2023-01-24End: 2024-11-16Updated: 2025-10-03

Phase 2

Efficacy of SLITone in House Dust Mite Allergic Patients

CompletedNCT00633919

ALK-Abelló A/SAllergy

Start: 2006-07-31End: 2009-02-28Updated: 2011-06-08

Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center

TerminatedNCT04492358

Maria Joyera RodríguezCovid19

Start: 2020-10-22End: 2021-05-31Updated: 2023-02-21

Treatment Efficacy of Corticosteroids and Mycophenolate Mofetil in Patients With Immune Related Hepatitis

Inge Marie SvaneHepatitis, Drug-Induced

Start: 2021-04-07End: 2025-11-07Target: 60Updated: 2022-12-14

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Czech Lymphoma Study GroupLymphoma, T-Cell, Peripheral

Start: 2021-10-31End: 2024-10-31Target: 33Updated: 2021-09-01

The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation

Hongqian GuoMetastatic Prostate Cancer, Prostate Cancer, Prostate Carcinoma

Start: 2022-03-01End: 2024-12-01Target: 30Updated: 2022-10-25

Orelabrutinib Combined With Rituximab Versus R-CVP in the Untreated MZL： A Randomized, Open Phase II Trial

RecruitingNCT06700798

Fei LiMarginal Zone Lymphoma(MZL)

Start: 2024-12-01End: 2027-12-04Target: 90Updated: 2025-06-17

Phase 4

Do We Need to Taper Down Steroid Therapy for Bell's Palsy

Carmel Medical CenterBell Palsy

Start: 2020-05-12End: 2023-08-01Target: 124Updated: 2020-07-28

Unknown Phase

A Prospective Study on Optimizing Treatment for ABPA

Shanghai Zhongshan HospitalAllergic Bronchopulmonary Aspergillosis

Start: 2021-11-15End: 2023-12-30Target: 100Updated: 2021-11-22

Short-term Oral Prednisone for Acute Subjective Tinnitus

CompletedNCT05591144

Eye & ENT Hospital of Fudan UniversityTinnitus, Subjective

Start: 2022-10-30End: 2024-02-03Updated: 2025-02-28

Different Dosing Regimens of STOP-AST

Eye & ENT Hospital of Fudan UniversityHearing Loss, Sensorineural Hearing Loss, Tinnitus

Start: 2023-11-10End: 2024-11-30Target: 162Updated: 2023-11-13

The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP

RecruitingNCT06479304

Yunfeng ChengImmune Thrombocytopenia With Positive ANA Antibodies

Start: 2024-04-24End: 2026-12-31Target: 129Updated: 2024-06-28

Related Papers

Prospective study of patients with immune checkpoint inhibitor-induced hepatitis; characterization of liver injury, outcome of therapy, and management of steroid-unresponsive and steroid-dependent hepatitis.

2026-03-05

A prospective phase II study to evaluate olaparib plus abiraterone and prednisone combination therapy in metastatic hormone sensitive prostate cancer patients with HRR gene mutation: Updated analysis of PROact.

Journal of Clinical Oncology2025-02-10

PROact: A prospective phase II study to evaluate olaparib plus abiraterone and prednisone combination therapy in patients with metastatic hormone sensitive prostate cancer with HRR gene mutation.

Journal of Clinical Oncology2024-06-01

FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities

Clinical Drug Investigation2022-09-293 citations